234 related articles for article (PubMed ID: 37484956)
1. Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome.
Pierotti L; Pardi E; Dinoi E; Piaggi P; Borsari S; Della Valentina S; Sardella C; Michelucci A; Caligo MA; Bogazzi F; Marcocci C; Cetani F
Front Endocrinol (Lausanne); 2023; 14():1191040. PubMed ID: 37484956
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1.
Vidal A; Iglesias MJ; Fernández B; Fonseca E; Cordido F
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):835-8. PubMed ID: 18435740
[TBL] [Abstract][Full Text] [Related]
3. Beyond the "3 Ps": A critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1.
Waguespack SG
Front Endocrinol (Lausanne); 2022; 13():1029041. PubMed ID: 36325452
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene.
Pack S; Turner ML; Zhuang Z; Vortmeyer AO; Böni R; Skarulis M; Marx SJ; Darling TN
J Invest Dermatol; 1998 Apr; 110(4):438-40. PubMed ID: 9540988
[TBL] [Abstract][Full Text] [Related]
5. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1.
Darling TN; Skarulis MC; Steinberg SM; Marx SJ; Spiegel AM; Turner M
Arch Dermatol; 1997 Jul; 133(7):853-7. PubMed ID: 9236523
[TBL] [Abstract][Full Text] [Related]
6. MEN1 clinical background.
Igaz P
Adv Exp Med Biol; 2009; 668():1-15. PubMed ID: 20175448
[TBL] [Abstract][Full Text] [Related]
7. Multiple endocrine neoplasia type 1.
Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
[TBL] [Abstract][Full Text] [Related]
9. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
Marini F; Giusti F; Brandi ML
Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
[TBL] [Abstract][Full Text] [Related]
10. Contribution of genetic analysis in screening for MEN1 among patients with sporadic disease and one or more typical manifestation.
Odou MF; Cardot-Bauters C; Vantyghem MC; Carnaille B; Leteurtre E; Pigny P; Verier-Mine O; Desailloud R; Porchet N
Ann Endocrinol (Paris); 2006 Dec; 67(6):581-7. PubMed ID: 17194968
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
[No Abstract] [Full Text] [Related]
12. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
[TBL] [Abstract][Full Text] [Related]
14. Frequency of facial angiofibromas in Japanese patients with multiple endocrine neoplasia type 1.
Sakurai A; Matsumoto K; Ikeo Y; Nishio SI; Kakizawa T; Arakura F; Ishihara Y; Saida T; Hashizume K
Endocr J; 2000 Oct; 47(5):569-73. PubMed ID: 11200937
[TBL] [Abstract][Full Text] [Related]
15. Multiple endocrine neoplasia type 1: new clinical and basic findings.
Schussheim DH; Skarulis MC; Agarwal SK; Simonds WF; Burns AL; Spiegel AM; Marx SJ
Trends Endocrinol Metab; 2001; 12(4):173-8. PubMed ID: 11295574
[TBL] [Abstract][Full Text] [Related]
16. Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
Igreja S; Chahal HS; Akker SA; Gueorguiev M; Popovic V; Damjanovic S; Burman P; Wass JA; Quinton R; Grossman AB; Korbonits M
Clin Endocrinol (Oxf); 2009 Feb; 70(2):259-64. PubMed ID: 18710468
[TBL] [Abstract][Full Text] [Related]
17. Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features.
Pardi E; Borsari S; Saponaro F; Bogazzi F; Urbani C; Mariotti S; Pigliaru F; Satta C; Pani F; Materazzi G; Miccoli P; Grantaliano L; Marcocci C; Cetani F
PLoS One; 2017; 12(10):e0186485. PubMed ID: 29036195
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
[TBL] [Abstract][Full Text] [Related]
19. Angiofibromas in multiple endocrine neoplasia type 1.
Vashi N; Hunt R; Fischer M; Meehan S; Pomeranz MK
Dermatol Online J; 2012 Dec; 18(12):20. PubMed ID: 23286810
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
Gaztambide S; Vazquez F; Castaño L
Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
